Jackson Walker L.L.P. recently assisted client QSpex Technologies, Inc. in securing approximately $20.5 million in Series D funding, which will enable the company to expand its production capacity and increase its sales and marketing staff to support a major U.S. product launch. Based in Alpharetta, Georgia, QSpex uses proprietary technology to develop systems that enable vision care providers to efficiently produce a wide range of top-quality spectacle lenses with a variety of premium features.

The equity investment was led by Spindletop Healthcare Capital of Austin, a late-stage venture capital firm that specializes in healthcare investments, and Essex Woodlands, one of the world’s largest healthcare growth equity and venture capital firms.

Jackson Walker partner Jeff Harder represented QSpex in the deal. Mr. Harder’s extensive experience working with both venture capitalists and emerging businesses enabled him to deliver exceptional results for his client in completing this important transaction.